What you should know:
1. RTW Investments and Perceptive Advisors co-led the fund, with Osage University Partners and entities affiliated with Paul Manning contributing.
2. The company will use the funds to support the development of its ulcerative colitis and Crohn’s disease drug candidate, as well as additional pipeline candidates.
3. RTW Investments and Perceptive Advisors each appointed a person to Landos’ board as a result of the investment.
More articles on surgery centers:
10 ASC industry key notes
Pennsylvania ASC plans to take Horizon insurance
7 ASCs, surgeons introducing robotics in 2019
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.